Asarfi Hospital Ltd is Rated Buy by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO’s 'Buy' rating for Asarfi Hospital Ltd indicates a positive outlook on the stock, suggesting that investors may consider adding or holding the stock in their portfolios. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. The rating was revised from 'Hold' to 'Buy' on 25 May 2026, reflecting an improvement in the company’s overall mojo score from 67 to 74. This score is a composite measure that captures various aspects of the company’s performance and market positioning.

Quality Assessment

As of 31 May 2026, Asarfi Hospital Ltd holds an average quality grade. This reflects a stable operational foundation with consistent earnings and a manageable debt profile. The company demonstrates a strong ability to service its debt, with a Debt to EBITDA ratio of 1.96 times, which is considered low and indicates prudent financial management. Furthermore, the company has declared positive results for the last four consecutive quarters, signalling operational consistency and resilience in a competitive hospital sector.

Valuation Attractiveness

The valuation grade for Asarfi Hospital Ltd is classified as very attractive. Currently, the company’s Return on Capital Employed (ROCE) stands at 15.6%, which is a robust indicator of efficient capital utilisation. The Enterprise Value to Capital Employed ratio is a modest 2.9, suggesting that the stock is reasonably priced relative to the capital it employs to generate profits. Additionally, the company’s Price/Earnings to Growth (PEG) ratio is 0.4, which is well below 1, signalling that the stock may be undervalued relative to its earnings growth potential. This valuation profile makes the stock appealing for investors seeking growth at a reasonable price.

Financial Trend and Growth Metrics

The financial trend for Asarfi Hospital Ltd is positive, supported by strong growth in key metrics. As of 31 May 2026, the company’s net sales have grown at an annual rate of 27.7%, while operating profit has expanded at an even faster pace of 34.16%. The latest six-month period shows a profit after tax (PAT) of ₹9.34 crores, reflecting a growth rate of 48.96%. Net sales for the same period reached ₹91.34 crores, growing by 34.34%. The operating profit to interest coverage ratio is notably high at 10.87 times, underscoring the company’s ability to comfortably meet interest obligations. Over the past year, the stock has delivered a return of 50.61%, outpacing many peers in the hospital sector and signalling strong investor confidence.

Technical Outlook

From a technical perspective, Asarfi Hospital Ltd is mildly bullish. Despite a recent one-day decline of 2.51% and a one-month dip of 12.41%, the stock has shown resilience with a three-month gain of 20.56% and a year-to-date return of 1.14%. The one-year return of 50.61% further confirms the stock’s upward momentum. This technical profile suggests that the stock is currently in a favourable position for investors looking to capitalise on positive price trends, although short-term volatility remains a consideration.

Investor Implications

For investors, the 'Buy' rating on Asarfi Hospital Ltd signals a stock with solid fundamentals, attractive valuation, positive financial trends, and a supportive technical backdrop. The company’s microcap status in the hospital sector offers potential for growth, especially given its consistent quarterly performance and strong profitability metrics. However, investors should remain mindful of sector-specific risks and market volatility that can affect stock price movements in the short term.

Company Profile and Shareholding

Asarfi Hospital Ltd operates within the hospital sector and is classified as a microcap company. The majority shareholding is held by promoters, which often indicates stable management control and alignment with shareholder interests. The company’s focus on healthcare services positions it well to benefit from ongoing demand in the sector, supported by demographic trends and increasing healthcare expenditure.

Summary of Key Financial and Market Metrics

As of 31 May 2026, Asarfi Hospital Ltd’s financial health is underscored by a strong debt servicing capacity, with a Debt to EBITDA ratio of 1.96 times. The company’s net sales and operating profit growth rates of 27.7% and 34.16% respectively highlight robust operational expansion. Profit after tax growth of nearly 49% over the latest six months further confirms improving profitability. The stock’s valuation metrics, including a PEG ratio of 0.4 and ROCE of 15.6%, indicate that the company is attractively priced relative to its growth prospects. The technical indicators, while showing some short-term fluctuations, maintain a mildly bullish stance, supporting the overall positive outlook.

Conclusion

In conclusion, Asarfi Hospital Ltd’s 'Buy' rating by MarketsMOJO reflects a well-rounded investment case supported by solid fundamentals, attractive valuation, positive financial trends, and encouraging technical signals. Investors seeking exposure to the hospital sector with a focus on growth and value may find this stock a compelling addition to their portfolios. The company’s consistent quarterly performance and strong profitability metrics provide a foundation for sustained growth, while its reasonable valuation offers a margin of safety in an often volatile market environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →